INSECTICID Insecticides (India) Q4 FY26 results (Jan–Mar 2026) and concall
Insecticides India Limited reported a resilient Q4 and FY26, with revenue growing 7% for the full year and 19% in Q4, driven by premium products. Margins saw significant improvement over a three-year period. The company is strategically focused on premiumization, R&D, and expanding its distribution through new platforms like Kaeros. Despite challenges from raw material inflation and a sluggish market in May, management remains cautiously optimistic for FY27, expecting positive top-line and bottom-line growth.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 18.7%, net profit down 14.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 627 | 358 | 359 | 691 | 638 +2% | 385 +8% | 426 +19% |
| EBITDA | 90 | 31 | 28 | 85 | 89 −1% | 27 −13% | 25 −11% |
| Net profit | 61 | 17 | 14 | 58 | 59 −3% | 10 −41% | 12 −14% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
